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Clinical Insights into the 
Importance of Scars and Scar 
Release in Paediatric Chronic 
Myofascial Pain
Gillian Lauder and Nicholas West
Abstract
Humans exhibit biotensegrity, whereby the whole body is a three-dimen-
sional visco-elastic vehicle whatever position it adopts: bones form non-contact 
compression struts embedded in a networked and tensioned myofascial matrix; 
each part of the organism combines with the mechanical system to create an 
integrated functional movement unit and contributes to the stability of the 
whole system. When tissue at/below the dermis is breached by surgery/injury, 
healing leads to scar tissue formation. Scars can cause local and distant effects 
that are not purely cutaneous. Restriction of normal movement of underlying 
tissues from defective fascial sliding generates anomalous tension that affects 
the fascial continuum leading to distorted biomechanics, altered biotensegrity 
and chronic pain. Scars are common in children and significant contributors to 
chronic pain presentations. Scars can be released (soft tissue mobilization and/
or needling) to sustainably improve pain, flexibility and range of motion. This 
chapter outlines the importance of skin and fascia in the biotensegrity model. 
Emphasis is placed on the fundamental need to assess scar history and scar 
characteristics to determine if scars should be treated as a component of mul-
tidisciplinary chronic pain management. Case studies outline some key clinical 
observations. Appropriately controlled research studies are required to fully 
demonstrate the highlighted benefits.
Keywords: chronic pain, paediatric pain, myofascial pain, scars, scar release, 
treatment approaches, fascia, biotensegrity
“Scars have the strange power to remind us that the past is real”.
Cormac McCarthy, All the Pretty Horses.
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1. Introduction
1.1 Skin
“Our skin mediates the most important transactions of our lives, Skin is key to our 
biology, our sensory experience, our information gathering, and our relationships 
with others……although rarely appreciated, it is one of the most remarkable and 
highly versatile parts of the human body.”
Nina Jablonski, Skin – A Natural History [1]
The skin is the largest organ in the body. It provides a crucial interface between 
the body and its environment. It has very diverse functions, which include: a defen-
sive barrier against toxic agents and micro-organisms, a multidimensional sensor 
between the body and the external environment, a protective shield from sunlight, 
a harnesser of sunlight to begin the process of Vitamin D production in the body, 
and host to a large part of our microbiome [1, 2]. The skin is thinnest at the eyelids 
and thickest on the soles of the feet. Skin consists of the epidermis and the dermis, 
which differ markedly in their structure and function.
The epidermis, the outermost layer is a stratified keratinizing epithelium, 
approximately 1 mm thick, which is in constant turnover. It maintains a shield 
against environmental toxins, resists water and protects against heat. The main 
types of cell found in the epidermis are the keratinocytes, but there are also melano-
cytes, Langerhans cells, T-lymphocytes and Merkel cells.
Basal keratinocytes are known to differentiate and flatten out to create the 
stratum corneum. The balance of proliferation and differentiation of the basal kera-
tinocytes is essential for epidermal integrity and ongoing epidermal tissue renewal. 
Keratinocytes are in close physical contact with free sensory afferent nerve endings 
and therefore involved in nociceptive responses [3]. Keratinocytes also have some 
specialised functions, such as: synthesis of keratin, neuropeptides, neurotrans-
mitters, endogenous opioids and autacoids; involvement in local inflammatory 
responses; as well as expression of multiple different receptors [3]. Tactile stimula-
tion is known to induce peripheral oxytocin release from keratinocytes to mediate 
local, peripheral oxytocin mediated analgesia [4]. In addition, keratinocytes play a 
fundamental role in the pathogenesis of neuropathic pain and central sensitization 
[3, 5–8]. Keratinocytes play a significant role in skin tissue repair, but an abnormal 
balance of proliferation and differentiation of keratinocytes may lead to generation 
of pathological scars [9].
Melanocytes are responsible for the primary pigment colour of the skin and the 
production of melanin. Melanin content is the differentiator for skin colour. Lighter 
skin or depigmented skin has less melanin, associated with living in more northern 
climates, where the lighter skin can synthesise more Vitamin D from exposure to 
sunlight. Merkel corpuscles are skin mechanoreceptors, whereas Langerhans cells 
and the T-lymphocytes have immunomodulatory properties.
The dermis is a thick layer of connective tissue, which is elastic, pliable, and has 
substantial tensile strength. The dermis is split into the upper papillary dermis, and 
the lower reticular dermis. The reticular dermis is characterised by dense irregularly 
packed collagen, elastin, and reticulin, from which it derives its name. It will be 
seen later that the duration and intensity of the inflammatory process within the 
reticular dermis, following surgery or injury, has an impact in the development of 
pathological scars. The dermis houses other essential organs of the skin including 
hair follicles, sebaceous glands, endocrine glands and apocrine glands which are 
absent in scarred skin.
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Whereas the primary cells of the epidermis are the keratinocytes, the primary 
cells of the dermis are the fibroblasts. The dermis gets its strength from a combina-
tion of collagen and elastin fibres. The fibroblast is a connective tissue cell that 
secretes collagen, elastin and other elements of the extracellular matrix. Collagen 
bundles in healthy normal skin are organised in a three-dimensional basket-weave 
pattern [10], whereas collagen bundles in scarred skin are organised in parallel to 
the epithelial surface [11]. Fibroblasts are critical in all phases of wound healing, 
wound contraction, and remodelling of scars. There are multiple distinct sub-
populations of dermal fibroblasts. Fibroblasts with abnormal phenotypes (altered 
proliferation profile and different patterns of cytokine release) are associated with 
the development of pathological scars [12].
There are different receptors within the skin, which include: Meissner’s cor-
puscles for light touch; Merkel’s discs for constant pressure; Pacinian corpuscles 
for deep pressure or vibration sense; and Ruffini corpuscles for skin stretch and 
temperature sensation. The skin is also a primary site of small fibre nociceptive end-
ings [13]. Underneath the dermis is the subcutaneous layer, which contains fat that 
insulates us to prevent heat loss, and fascial layers that give the skin mobility relative 
to the muscles, tendons and bones.
Adipose tissue has long been considered just a means of fat storage. However, 
it has important metabolic and endocrine functions. Regulation of whole-body 
energy metabolism occurs through its storage function in white, brown or beige 
adipocytes. Its endocrine function occurs through production of adipocytokines, 
including leptin and adiponectin. Neurons of the sympathetic nervous system 
innervate different fat deposits to create communication with adipocytes. Leptin 
is hormone secreted from white adipose tissue to alter the sympathetic outflow 
centrally. This leptin-dependent neuro-adipose tissue connection plays an impor-
tant part in regulating lipolysis and thermogenesis [14]. Leptin also acts on the 
hypothalamus to regulate food intake [15]. Adiponectin, also a protein hormone 
produced by adipocytes, has organ protective functions that result from the binding 
of adiponectin to receptor sites on many organs to activate exosome formation and 
release for cellular haemostasis [16]. Adiponectin and adipocytes are key players in 
skin health and disease [17].
The skin is electrically active and contains many nerve elements for interaction 
with the nervous system [18], the autonomic nervous system [18, 19], and the loco-
motor apparatus [20]. There is continual nervous activity, in afferent and efferent 
mode, between the skin and central nervous system to maintain normal physi-
ological and biomechanical homeostasis [18, 21]. There is an independent central 
emotional connection, principally between the anterior cingulate cortex and the 
skin, whereby a sympathetic electrical signal can be detected in the skin in response 
to viewing emotionally charged images [22].
1.2 Touch
Information from skin sensors is relayed via A-delta and C-tactile fibres to the 
spinal cord and from there to the thalamus, then to specific regions in the primary 
somatosensory cortex and further on to higher somatosensory areas. The somato-
sensory maps are not represented in direct proportion or alignment to the body. 
Certain regions are magnified in response to the density of mechanoreceptors in 
the associated skin; for example, fingers and lips. The brain receives converging 
input from numerous nerves innervating adjacent regions of the skin to enable 
recognition of a specific touch sensation. Neuroplastic adaptive changes occur in 
the somatosensory map related both to increased repetitive activity and to disuse. 
Although the primary somatosensory cortex responds appropriately to touch 
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information, the brain’s higher centres are more strongly influenced by cognitive 
factors, such as expectations, context, and attention.
Wide dynamic range neurones integrate afferent pain and touch information. 
Others converge afferent viscero-somatic information into the spinal cord [23, 24]. 
Integration of these pathways can sometimes lead to sensory illusions. For example, 
referred pain is exemplified by shoulder pain from irritation of air under the 
diaphragm, or left arm pain in association with angina. Conversely, convergence 
of efferent sensory and sympathetic innervation to skin vasculature may explain 
sympathetic involvement in conditions such as complex regional pain syndrome 
and fibromyalgia [25, 26].
It is clear that the skin is a versatile and important organ, but it cannot be consid-
ered in isolation from its underlying fascia when considering the impact of scars.
1.3 Fascia
“The unsung hero of spine biomechanics.”
M. Driscoll [27]
Fascia has long been thought of as the annoying tissue that has to be dissected 
off to get to the underlying anatomy. This traditional view of fascia has now been 
surpassed. The most up to date definition describes fascia as a sheath, a sheet or any 
number of dissectible aggregations of connective tissue that forms beneath the skin 
[28]. However, this definition is too simplistic, and it is the definition of the fascial 
system that highlights the importance of fascia in biomechanical regulation:
“The fascial system consists of the three-dimensional continuum of soft, collagen 
containing loose and dense fibrous connective tissues that permeate the body. 
It incorporates elements such as adipose tissue, adventitiae and neurovascular 
sheaths, aponeuroses, deep and superficial fasciae, epineurium, joint capsules, liga-
ments, membranes, meninges, myofascial expansions, periostea, retinacula, septa, 
tendons, visceral fasciae, and all the intramuscular and intermuscular connective 
tissues including endo-/peri-/epimysium. The fascial system surrounds, interweaves 
between, and interpenetrates all organs, muscles, bones and nerve fibres, endowing 
the body with a functional structure, and providing an environment that enables 
all body systems to operate in an integrated manner.”
Adstrum et al. [29], Stecco et al. [30] in Adstrum and Nicholson [28]
Fascia is multi-layered and has both loose and hard fibrous connective tissue com-
ponents. Loose fascia functions to help slide and glide between structures and dense 
fascia exerts a tensile strength in tissues like tendons. Fascia and muscle tissue have a 
complex interplay to achieve skeletal balance, co-ordination, posture, and locomotion.
Fascia contains cells (fibroblasts, fasciacytes, myofibroblasts, and telocytes), 
an extracellular matrix (ECM), nerve elements (proprioceptors, interoceptors, 
and nociceptors), and a system of vascular micro-channels (the primo vascular 
system) [30, 31]. The fasciacytes produce hyaluronan in response to shear stresses 
[32]. Hyaluronan (formerly known as hyaluronic acid or hyaluronate) is a gly-
cosaminoglycan of the ECM. Hyaluronan exists between fascia and muscle and 
promotes sliding and gliding between fascia, muscle, blood vessels, nerves, and 
lymph channels. It is one of the most important determinants of the viscoelastic 
properties of a tissue [32–35]. The fascial fibroblasts produce collagen in response 
to load and stretching. Both acute and chronic fascial loading stimulate collagen 
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re-modelling [36]. Myofibroblasts within large sheets of fascia are considered 
to exert clinically significant change in fascial tension in response to sustained 
mechanical tension, cytokines, low pH, oxytocin, and other agents such as nitric 
oxide. The myofibroblasts’ contractile properties may contribute to spasms, dys-
function, and pain [18, 37]. Telocytes are probably important in regeneration [38]. 
Fascial tissue has highly variable density, stiffness, humeral action, and metabolic 
activity, depending on its location and purpose [23].
As the fascia envelops every structure within the body, it creates structural con-
tinuity that provides form and function to every tissue and organ. Fascia is one of 
the essential biological structures that combines with muscles, tendons and bones 
to create the tensioned and compressed parts that create the biotensegrity proper-
ties of the human body [40]. Fascia has active mechanical, proprioceptive, nocicep-
tive, and biomechanical and biotensegral properties [30, 39, 41]. Fascia is essential 
for physiological and metabolic haemostasis as well as healing and repair [30, 31]. 
Fascia conveys mechanical forces directly or indirectly: directly through muscles at 
the attachments to bones [42]; or indirectly, as extramuscular fascial chains [43]. 
There is evidence to support the existence of five myofascial chains (superficial 
back line, back functional line, front functional line, lateral line and spiral line, 
see Figure 1) [39], which work within the biotensegrity model [44]. These chains 
have opposing chains mirrored on either side of the body to achieve balance within 
the musculoskeletal system. This emphasises the complex nature of human move-
ment and why range of motion at one peripheral articulation is dependent on the 
positioning of the entire myofascial chain system of the body [45]. Like the skin, 
fascia is also innervated by the autonomic nervous system and afferent free nerve 
endings [23, 46] and can be considered as a sensory organ of human biomechanics 
[23, 46–48]. Fascial tissue homeostasis is a complex, inadequately elucidated, inter-
action which depends upon active communication between cellular components of 
the fascia and the related ECM [43, 49].
1.4 The extracellular matrix
“The Organ of Form”
Varela and Frenk [50]
Figure 1. 
Myofascial chains, from left to right: spiral line, lateral line, front functional line, back functional line, and 
superficial back line (adapted from Wilke et al. [39], with permission from Elsevier).
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The extracellular matrix (ECM) is defined by Grey’s Anatomy as “the extra 
cellular components of connective and supporting tissues. Essentially, it consists of a 
system of insoluble protein fibres, adhesive glycoproteins and soluble complexes composed 
of carbohydrate polymers linked to protein molecules (proteoglycans and glycosaminogly-
cans), which bind water. The ECM distributes the mechanical stresses on tissues and also 
provides the structural environment of the cells embedded in it, forming a framework to 
which they adhere and on which they can move. It provides a highly hydrated medium, 
through which metabolites, gases and nutrients can diffuse freely between cells and the 
blood vessels traversing it” [51].
The ECM is present within every tissue of the body to provide fundamental 
physical scaffolding for the cellular constituents and orchestrate vital biochemical 
and biomechanical functions required for morphogenesis, differentiation, and 
homeostasis. The ECM is basically composed of water, salts, and macromolecules 
consisting of fibrous proteins (collagen, elastin), adhesive glycoproteins (lam-
inin, fibronectin, tenascin, integrin), and carbohydrate polymers (proteoglycans 
and glycosaminoglycans). Collagen is the most abundant ECM fibrous protein. 
However, each individual tissue has a heterogeneous ECM composition providing 
highly variable but unique biochemical, protective, organisational and biomechani-
cal ECM properties, which differ from one tissue to another. This composition is 
primarily dependant on that tissue’s particular function [52]. The ECM is a highly 
dynamic structure, constantly being remodelled with its molecular components 
subject to a multitude of modifications.
Morphological organisation and physiological function of the ECM is orches-
trated by binding growth factors and interacting with cell-surface receptors to elicit 
signal transduction and regulate gene transcription. Enzymes released from fascial 
cells degrade the ECM, such as cathepsins, heparinase, hyaluronidases, and metal-
loproteases, to maintain normal tissue turnover.
Matrix metalloproteinases (MMPs) are key in ECM remodelling as they 
degrade matrix components. MMPs are classified according to substrate specificity; 
for example, collagenases or gelatinases [52]. It will be seen later that the ratio of 
MMPs to MMP-inhibitors is of importance in the development of atrophic scars.
2. Scars
2.1 The healing of wounds and scar creation
Any breach of the dermal layer will result in a scar. When the dermis is breached 
by surgery or injury, a healing process occurs that leads to the formation of scar 
tissue [53]. There are two main types of healing: primary intention and secondary 
intention. Healing by primary intention occurs in wounds with dermal edges in 
close proximity; for example, a surgical incision. Healing by secondary intention 
occurs when there is unavoidable tissue loss with abnormal tension, infection or 
necrosis, creating a large deficit where the sides of the wound are not opposed or 
too big to heal by primary intention; therefore, healing must occur from the bottom 
of the wound upwards. For both primary and secondary intention healing, there 
are three overlapping stages to healing after haemostasis is achieved; inflammation, 
proliferation, and remodelling [54]. This extremely complex and co-ordinated 
process is guided by cytokines plus chemokines secreted by platelets, macrophages, 
endothelial cells, keratinocytes, fibroblasts, and adipocytes [2, 12, 17, 18, 55, 56].
Wound healing and scar maturation can take years to complete, but depend 
on the size and nature of the initial wound. During remodelling, type 3 collagen is 
replaced by a stronger type 1 collagen, but not in an ordered manner. Scar tissue 
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is therefore strong, but not as elastic or flexible as normal tissue [37, 54]. Normal 
scars first appear as a red line, but maturation results in a slightly broadened white 
line, in the same plane with the surrounding skin, known as a normotrophic scar. 
Normotrophic mature scars are less innervated than the surrounding normal skin 
[57, 58]. Scar tissue, therefore, has different properties to the tissue it replaced prior 
to injury. Skin healing is not just dependent on the size and site of the wound, but 
is also influenced by bacterial contamination, nutrition, comorbid medical condi-
tions, as well as genetic and epigenetic factors [56, 57]. Once normotrophic scars are 
established, they are often forgotten and ignored unless they constitute a cosmetic 
embarrassment.
2.2 Scar morphology
If the healing process is interrupted by tissue disruption, infection or a comor-
bid disease process, then a pathological scar may occur, which may be atrophic, 
hypertrophic, tethered, or keloid in nature. Development of pathological scars 
may be related to genetics, as well as differences in the duration, and intensity of 
the inflammatory process in the reticular dermis [56, 59–61]. Excessive scar tissue 
movement, scar rubbing, scar scratching or abnormal tension related to surgery or 
injury may also induce an enhanced neurogenic inflammatory response [18, 62–65]. 
This may be an important consideration when reflecting on what constitutes a 
significant scar in terms of myofascial dysfunction later.
Atrophic scars are concave indentations resulting from tissue loss (including col-
lagen) associated with relative shift in the ratio of MMPs to tissue inhibitors of MMPs 
that favours a lytic process and the development of an atrophic scar [66]. Chicken pox 
scars are atrophic, which can occur in up to 20% of children following chicken pox 
infection [67, 68]. Acne scars are a common problem in developed countries, occur-
ring in 80% of 11–30 years old and 5% of adults aged over 30 years [69]. Acne scars 
are usually atrophic, subdivided into rolling, boxcar, or ice-pick. However, acne scars 
can also present in hypertrophic or keloid morphology. Hypertrophic scars and keloid 
scars have excess deposition of collagen. Hypertrophic scars form early within the 
time frame of injury and remain within the boundaries of the inciting injury. Keloid 
scars have excess thickened hyalinized collagen. Keloid scars may have a delayed 
onset of formation and extend beyond the boundaries of the original scar. Keloid 
scars are more likely to occur in dark-skinned individuals, between ages 10–30, at 
times of peak hormones (puberty, pregnancy), with a positive family history, and in 
association with hyperimmunoglobulinemia E, or blood type A [70].
2.3 Scar assessment
Clinical documentation of scar size, thickness, and treatment effects are usually 
performed with the use of serial photographs, scar scales (such as the Vancouver 
Scar Scale, VSS), and validated questionnaires, such as the Patient and Observer 
Scar Assessment Scale (POSAS) or Dermatology Life Quality Index (DLQI). 
There are few reliable, objective non-invasive tools to measure scar characteristics. 
Ultrasonography and high-definition optical coherence tomography (HD-OCT) 
have also been reported for objective measurement of scars [71–73]. Scar pliabil-
ity (mechanical property of the skin’s stiffness, extensibility, and adherence) is 
measured using adheremeters, cutometers, and ultrasonography [74]. Viscoelastic 
properties of scars and connective tissue around scars are measured using sono-
elastography [75–78]. Scar colour can be assessed using narrow-band reflectance 
spectrophotometry colour analysis or Tristimulus colour systems [79], and scar 
perfusion can be measured with Laser Doppler Flowmetry [79].
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2.4 Scar management
Scar optimization and mitigation are key principles that are vitally important 
in medical practice, but beyond the scope of this article. Readers are directed to 
algorithms of management that exist for both the adult and paediatric populations 
[70, 80–83].
2.5 Asymptomatic or symptomatic scars
Diverse symptoms can occur in up to 70% of patients with scars [74]. Symptoms 
can occur at random timing and even at long intervals after wound healing. Some of 
these symptoms are highlighted in Figure 2.
Scars may be intrinsically painful or play a role in pain located at an anatomi-
cally distant site. Scars may present as painful or itchy at the site of the healed scar. 
One potential cause of intrinsic pain in a healed scar is a neuroma, derived from 
a regenerating nerve trapped in the fibrotic scar tissue. This is usually associated 
with numbness in the innervated area of the injured nerve and a positive percussion 
test. In the absence of a neuroma, the estimated prevalence of painful scars is 2%, 
but increases in the burn population to 30–68% [57]. Intrinsic scar pain occurs in 
7–18% of patients following lower segment Caesarean section [84–86]. Pathological 
and intrinsically painful scars have been shown to have an in imbalance between 
non-peptidergic unmyelinated c-fibres and peptidergic c-fibres, but not necessarily 
in total nerve fibre density [57]. There is also an increased abundance of neuropep-
tides, and nociceptors in pathological scars, especially hypertrophic scars [18, 87].
It is clear that what is happening underneath a scar is critical to whether it 
subsequently creates symptoms. Scar tissue can adhere to fascia, underlying 
muscles, organs, blood vessels and nerves, and recognition has been given to scars 
as an etiological factor in post-surgical visceral dysfunction [88, 89], nerve entrap-
ment syndromes [90], and symptoms related to obvious contractures. However, 
very little is documented for the role of scars in locomotor dysfunction [91–95] or 
chronic myofascial pain [37, 95–97].
Figure 2. 
Symptoms related to scars.
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In patients asked to move actively, electrical activity from a scarred area is higher 
than that from normal tissue in the same patient doing the same movement [93]. 
Mechanoreceptors and mechanosensitive nociceptors in scarred areas may sense 
an alteration in tension from normal and send non-physiological signals creating a 
pathological reflex arc [18], inducing neurogenic inflammation and worsening scar 
formation and pain [18, 63].
2.6 How scars impact fascia, muscles and movement
“Any skin injury, like a scar, even if small, affects the organism and constitutes an 
active obstacle to its normal functioning”
Alvira-Lechuz et al. [98]
Scars can limit normal movement and the flexibility of skin, the underlying 
fascia, and its associated muscles. It is clear that any scar that restricts fascial or 
muscular movement will also have an impact on whole body movement related to 
the myofascial chains discussed in the fascia section above [18, 99]. The fascia is 
recognised as a significant contributor to chronic pain [100–102]. Other factors that 
may play a role include alterations in fascial density. Changes in hyaluronan may 
lead to fascial densification that restricts fascial sliding and gliding, aggravating 
fascial dysfunction associated with musculoskeletal disorders and chronic pain 
[32, 103–109]. Injury reduces the flexibility of fascia; for example, a compound 
fracture may be associated with periosteal tethering to the skin during healing. The 
subsequent defective fascial sliding generates anomalous tension, which affects 
the fascial continuum leading to musculoskeletal pathology, pain and progressive 
immobility [18, 32, 103, 110–112]. Fascial injury also leads to fascial dysfunction as 
well as significant loss of sports performance [18, 21, 113, 114]. Symptoms may not 
necessarily just occur at the site of injury, but also at a distant site related to referred 
pain and impacts through myofascial chains. Reduced fascial mobility, related 
to movement restriction secondary to injury, worsens over time, but may persist 
even when movement is subsequently restored [110]. This was demonstrated with 
ultrasound imaging of adults with chronic low back pain with increased thickness 
and reduced mobility of the thoracolumbar fascia [102, 110, 115]. Sonoelastography 
has been used to measure viscoelastic properties of the connective tissue around 
scars: it superimposes a parametric image, in a range of colours, over the ultrasound 
anatomical scan image to semi-quantitatively correlate images with that tissue’s 
elasticity. Sonoelastography has been used to show the changes in post-surgical 
scars following manual therapy [75, 76].
Fascial trauma or injury may also irritate primary afferent nociceptive fibres 
leading to spinal cord wind up and central sensitization as another mechanism of 
ongoing pain [35, 96].
Myofascial pain is characterised by the presence of myofascial trigger points. 
Myofascial trigger points develop in response to many different insults such as: 
trauma, injury, surgery, repetitive microtrauma, poor posture, muscle overuse or 
overload. Myofascial trigger points that cause pain can originate in scars, skeletal 
muscle, and/or fascia. myoActivation® [116] is an innovative structured assess-
ment and therapeutic process targeting release of fascia (including scars) and 
muscles in sustained contraction.
myoActivation is unique in focusing on aspects of the immediate and past 
trauma history (often overlooked in a classical medical history) and relating 
this to the current chronic pain presentation. The timeline of lifetime trauma 
(TiLT) inventory explores all injuries, especially those occurring at a young age, 
mechanisms of injuries, healing processes, and the perceived physical impact of 
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Features in the past medical history 
and timeline of lifetime trauma 
(TiLT) inventory
Scars incurred at a young age, especially the first or earliest scar in 
childhood
Ongoing pain occurring in the immediate timeframe of a surgical 
procedure which is unexplained and resistant to other forms of 
therapy.
History of poor wound healing, wound infection or wound 
dehiscence
Painful/itchy scars
Scars incurred at a time of intense emotional turmoil or trauma.
History of mood disorders may indicate any chin scars will be 
significant
History of anxiety may indicate any chest wall scars will be 
significant
History of “brain fog” (confused, disorganised, find it hard to focus 
or put thoughts into words) may indicate a face/chin/sternal or 
midline abdominal scars will be significant
History of injury in the presence of an asymptomatic scar (injury 
may be months or years after scar acquisition), which results in pain 
in the region of this previously asymptomatic scar
Type of scars Scars related to chicken pox infection, surgery and especially 
surgical drain scars, burns and animal (or human) bites
Site of scar Over bony prominences, e.g. anterior chest, in feet, scar in region of 
main pain complaint, on the same side as a unilateral pain complaint
At sites of periosteal tethering
Scar characteristics Painful scars, purple discolouration, widened scar, palpable 
densities within or around the scar, scar dysesthesia, adherent/
tethered scars
myoActivation examination BASE 
test [116]
If scar is situated in region of most painful or restricted BASE test on 
myoActivation examination, even if it looks like a normal scar and/
or reported as asymptomatic
Response to dry needling release Enhanced “biting” sensation when scar is released with dry needling 
even with appropriate use of topical anaesthesia and/or vapo-
coolant spray
Reported pain decreased or moved immediately following scar 
release
Improvement in ROM and flexibility immediately following scar 
release
Decreased irritability of other palpable pain points in region of and 
distant to area of scar release
Size of scar Size of scar does not seem to play a factor as tiny epidural needle 
scars or chicken pox scars can be as significant as large surgical 
wounds.
Less significant scars Some scars seem to be less significant in terms of myofascial 
dysfunction and chronic pain, e.g.
• Superficial self-harm scars
• Tattoos (although they may be hiding another significant scar)
• Stretch marks
Table 1. 
Clinical factors indicating a scar may have potential for myofascial dysfunction and chronic pain.
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those injuries to that person. Assessment involves the use of a series of systematic 
movement tests (BASE tests) [116], postural observations and examination of 
tissues to find palpable pain points and determine if there are important myofas-
cial sources of perceived pain. A key principle in myoActivation is that the site of 
perceived pain is often not the true source of pain. The most painful or restricted 
movement on BASE tests identifies the most important tissues to treat first. Careful 
inspection and palpation of these tissues localises the myofascial source of pain. 
Treatment entails refined trigger point injections to restore anatomic integrity 
to injured tissues. Fine gauge hypodermic needles are inserted into trigger points 
that compromise function of muscle, ligament, tendon, subcutaneous fascia, scar 
tissue, and the peripheral nerves of the skin. After each individual myofascial area 
is treated, BASE movement tests are repeated to demonstrate immediate change 
and direct the clinician to the next most important target area. Several cycles 
occur during each myoActivation session to unravel multiple sources of myofascial 
dysfunction in a structured way, to help resolve chronic myofascial pain. Immediate 
treatment responses occur, which include reduction in pain, increased flexibility, 
and improved fluidity of movement. This process often reduces or resolves pain 
sufficiently to enable the subsequent weaning of prescription and over-the-counter 
analgesia medications [117]. myoActivation is not effective in all patients because 
pain perception is a complex biopsychosocial phenomenon, but determination of 
those who will respond rests with the TiLT inventory, clinical history and the series 
of BASE tests on examination.
Clinical experience with myoActivation [116] reveals that a scar can play a very 
significant role in chronic myofascial dysfunction and pain even if that scar has the 
appearance of a normotrophic scar and is reported to be asymptomatic. An ankle scar 
may alter the gait dynamics through maldistribution of myofascial loads [18] and 
may also present with ongoing pain at a distant site on the ipsilateral side. Patients 
with scars in the abdominal region, such as a Caesarean section scar or an abdomi-
noplasty scar, may present with low lumbar back pain related to impaired mobility 
of the soft tissues of the abdomen, which then puts stretch on the lumbar muscles, 
thoracolumbar fascia, and the posterior myofascial chain [92, 93, 112]. Scars may also 
have an impact on the distribution of forces that pass through the body at the time of 
an injury, such as during a motor vehicle accident [18], causing a previously asymp-
tomatic scar to be the inciting event for myofascial impairment and pain.
2.7 Significance for myofascial dysfunction and chronic pain
Classic scar assessment techniques such as use of adheremeters, cutometers, 
ultrasonography, and rating scales (POSAS or VSS) [74] were not designed to deter-
mine a scar’s relevance to myofascial dysfunction and pain. A scar may be significant 
in terms of myofascial dysfunction and chronic pain, but not be characterised as a 
pathological scar in current “classical” medical terminology. Clinical experience with 
myoActivation therapy has found some features, outlined in Table 1, that indicate a 
scar may cause significant myofascial dysfunction and/or chronic pain. These obser-
vations will have to be researched to determine which ones are the more common 
and substantial factors in myofascial pain and dysfunction.
3. Scar release
Non-surgical scar release can be achieved with soft tissue mobilisation tech-
niques, subcision or dry needling [84, 93, 118–121]. Subcision, or microneedling, 
also known as percutaneous collagen induction therapy, is a minimally invasive 
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minor surgical procedure used for treating depressed cutaneous scars and wrinkles. 
A simple hypodermic needle or a dermaroller are the tools used to effect subcision 
[122]. Subcision was first described in 1995 [123]. It is a safe and effective micronee-
dling technique used as an aesthetic treatment for several different dermatological 
conditions including scars, rhytids, and striae [122, 124, 125]. Histological changes 
have been demonstrated with this technique [126]. It is hypothesised that micronee-
dling stimulates the body’s own regenerative mechanisms through collagen bundle 
break down and new collagen formation (neocollagenesis), stimulation of the 
release of platelet and neutrophil derived growth factors and cytokines (FGF, 
TGFα, TGFβ, VEGF, FGF-76, EGF, platelet derived growth factor, connective tissue 
growth factor, and connective tissue activating protein), resulting in increased pro-
duction of collagen, elastin and glycosaminoglycans [122, 127–132]. Up-regulation 
of TGF-β3 (which prevents aberrant scarring) in excess of TGF-β1 and TGF-β2 may 
be responsible for the benefits seen with microneedling [129, 133].
The other physiological effects of dry needling are not yet fully elucidated, but 
may include local, hormonal, neuronal, and placebo effects [134]. Neuronal effects 
include: modulation of the peripheral nervous system; gate control mechanisms; 
and central pain modulation, such as activation of the diffuse noxious inhibitory 
control systems [135]. Dry-needling stimulation of skin nociceptive nerve fibres 
may release endogenous opioids to activate enkephalinergic inhibitory dorsal horn 
interneurons and oxytocin to mediate peripheral inhibition of c-fibre discharge [4].
For the release of scars, the myoActivation needling technique involves the 
sequential insertion of 30 g hollow bore needle in the line of the scar and in any 
areas of densification around the scar performing multiple perforations approxi-
mately 3 mm apart. Clinical experience reveals that a patient report of a “biting 
sensation” with needling is characteristic of a myofascially significant scar. This 
biting occurs even if the scar has been treated with appropriately timed topical 
anaesthetic or pre-needling vapocoolant spray.
The release of scars with micro-needling techniques has been shown to pro-
duce relief of chronic pain [116, 136]. Currently, the immediate relief of chronic 
pain following needling of surgical scars is limited to case reports [116, 120, 136], 
and to date there is insufficient evidence to advise on the right time to treat scars 
after injury or surgery. It has been suggested that the skin can keep a memory of  
trauma [118, 137]. It is clinically important to consider this and be cognizant of 
events which were associated with creation of a scar. Scars inflicted at a time 
of severe emotional distress or at the time of a traumatic event can be associ-
ated with flashbacks or emotional release at the time of, or a number of hours 
after, treatment whether the therapy was with a needling procedure or manual 
manipulation [138].
3.1 Effects of scar release
As all structures of the human body are intricately connected through skin and 
the myofascial system, scar and myofascial release (often at a distant site) can result 
in immediate improvement of pain, flexibility and range of motion [116] (Table 2), 
but it is imperative that this is combined in a multidisciplinary approach to address 
the whole biopsychosocial aspects of pain especially in the paediatric population 
[136]. It is absolutely essential to prevent needle-related pain in paediatric patients; 
the practitioner should employ a variety of non-pharmacological techniques includ-
ing distraction, breathing techniques, music, virtual reality or mobile devices. 
Pharmacological modalities can be added when non-pharmacological methods 
are considered insufficient to address the patient’s anxiety and needle-related 
pain. Topical anaesthetic cream can be applied to target sites (especially scars) an 
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hour before the appointment to minimise needle pain. Oral benzodiazepines can 
be useful for anxiolysis. If the above methods are not adequate, IV sedation with 
appropriate anaesthetic monitoring and care may have to be utilised.
Over and above these considerations there are some relative and absolute contra-
indications to needling of scars (Table 3).
4. Case based discussion of important points
Chronic myofascial pain is common in the paediatric population and its preva-
lence has increased since the 1980s [139]. Musculoskeletal pain is a common cause 
of pain in adolescents, with incidence ranging from 30 to 65% [140–144], and is a 
leading cause of years lived with disability among children and adolescents [145]; 
4% of all primary care consults represent musculoskeletal issues in children aged up 
to 15. Between 4 and 40% of adolescents report limb pain and 14–24% complain of 
Immediate effects Decreased pain or pain which has shifted to a new location
Increased flexibility and range of movement in myoActivation BASE tests
Altered weight distribution on feet
Emotional release
Reports of feeling lighter or “walking on a cloud”
Sympathetic response
Vasovagal response
Bruising
Post treatment pain at site of needle insertions lasting minutes to hours
Exacerbation of muscle spasms (requires additional needle insertions to resolve)
Adverse events (Injury to adjacent structures e.g. pneumothorax when needling 
around lung fields)
Long-term effects Improved pain
Improved flexibility
Improved mood
Improved sleep
Maturation to a normotrophic scars
Table 2. 
Effects of scar release.
Absolute New scars in process of normal healing and remodelling
At sites of active infection
Relative Near indwelling metalwork/hardware to minimise risk of hardware infection.
Near indwelling mesh to minimise risk of infection.
Where it is considered to be too painful (especially foot scars)
When patient has needle aversion or needle phobia
Table 3. 
Relative and absolute contra-indications to needling scars.
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low back pain [146]. The prevalence of paediatric chronic myofascial pain increases 
with increasing age [139, 147–150] and is more common in females [146, 151]. Young 
children are not immune with a 10% prevalence of musculoskeletal pain in 6-year-
old children. A staggering one-third of this six-year-old population has chronic 
musculoskeletal pain and 44.6% of them report that pain is multisite in nature [152].
Despite its prevalence, reported musculoskeletal pain is often under-diagnosed 
in adolescents [153, 154]. Healthcare providers may be unfamiliar or not trained to 
diagnose chronic pain, muscle trigger points, palpable pain points, and fascia in ten-
sion [155–158]. Presenting symptoms such as neck pain, shoulder pain, abdominal 
pain and headaches do not immediately direct a physician to look for a myofascial 
component to pain. Myofascial pain can also imitate other pathologies; for example, 
a trigger point in the quadratus lumborum muscle can mimic the symptoms of 
appendicitis on the ipsilateral side, or fascial tension in the peri-coccygeal soft 
tissues may present as neck pain. System, practice and time pressures may also limit 
the ability to undertake a full history and physical examination [159, 160].
Experience dictates that dysfunctions in muscles, fascia and scars are common 
in the paediatric population and are significant contributors to paediatric chronic 
pain [116, 136]. The following cases highlight the importance of scars in paediatric 
myofascial pain presentations. It must be emphasised that scars are not treated 
in isolation, but as one element of myoActivation, which is one component of 
multidisciplinary care.
The children described in these case studies were referred to the Complex 
Pain Service (CPS) at BC Children’s Hospital in Vancouver, Canada, and were 
treated within a program of multidisciplinary care based on the “3P” principle 
(Pharmacology, Physiotherapy, Psychology). The data for these case studies were 
collected with the approval of the University of British Columba/Children’s and 
Women’s Research Ethics Board (H20-01862).
4.1 Case 1: standard myoActivation assessment finding unreported scars
A 13-year-old, 54 kg female was referred to the CPS for management of multi-
site chronic pain of 3 years duration with a diagnosis of “pain syndrome” focused 
mainly on the left knee, but also affecting the low back and neck. The low back pain 
of 3 years was reported to be secondary to a fall 3 years previously. She had been 
involved in a motor vehicle accident (MVA) 2 years after that when she was struck 
on the left side whilst walking across a road. She was admitted by ambulance to 
the local emergency room (ER) and discharged later that day with a diagnosis of 
bruising to her left knee and ribs after normal imaging. She initially mobilised with 
crutches and gradually regained physical functioning, but with ongoing pain.
She described her current pain as dull and achy with stabbing pain elements. 
Pain was aggravated by walking long distances or any physical activities or exercise. 
She stated that she had some irritability and sadness related to her pain. She com-
plained about some inability to concentrate due to pain and had been absent from 
school for 21 days in the previous 3 months. She reported that pain also affected 
her ability to fall and stay asleep. Her TiLT inventory revealed no other injuries. She 
reported that she had no scars. She had been using acetaminophen and ibuprofen 
or naproxen for analgesia as required. She was otherwise healthy and her family 
history was unremarkable.
She was assessed by her orthopaedic surgeon and family doctor. Previous clas-
sical examination, imaging (X-rays and MRI) and bloodwork revealed no remedial 
cause of her pain.
myoActivation examination revealed unreported scars on the left knee and the 
right upper back, fascia in tension and multiple muscles in sustained contraction. 
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A myofascial component to her pain was diagnosed. She was enrolled in the 3P care 
plan. She was started on Magnesium Bisglycinate, Vit K2 and Vit D (MgBis/K2/D3). 
Written information about myoActivation was given to the family. One month later, 
there was a reduction in pain with improved fluidity of movements. Her family also 
reported improved mood and sleep.
4.1.1 myoActivation session 1
It was deemed appropriate to proceed with myoActivation at this one month 
follow up based on her stoical character. Written consent was obtained. Distraction 
techniques, vapocoolant spray and topical anaesthetic for scars were used to mini-
mise procedural pain. All needling was done using sterile technique.
The right thoracic paraspinal, right gluteus medius, right gluteus maximus 
and left iliopsoas were sequentially activated based on the repeat cycles of assess-
ment to determine the most restrictive and painful BASE tests [116]. The three 
left knee scars and upper back scar were in regions of worst BASE tests so they 
were considered significant and released. Scar release consisted of sequential 
perforation needling of the scar using a 30 g hollow bore needle. After this first 
myoActivation session the patient experienced immediate improvement in pain 
and flexibility.
4.1.2 myoActivation session 2
Five days after her first myoActivation session the patient reported that her low 
back pain no longer bothered her. She reported that the left knee pain felt less tight 
and tense and she was able to move “more freely”, but going up and down stairs was 
still a problem. The left lumbar paraspinal, left rectus femoris, left vastus lateralis 
and left pubic fascia were sequentially activated based on the repeat cycles of 
assessment to determine the most restrictive and painful BASE tests [116].
4.1.3 myoActivation session 3
At the next myoActivation session, 1 day later, the patient reported that her 
pain had moved to the medial aspect of her left knee overnight. Repeat myoActiva-
tion examination revealed marked improvement in all core BASE tests with no 
pain except mild limitation of squats with arms down and arms up. The left vastus 
medialis was activated with improvement in squat with the arms down. A left shin 
scar was noted and released with improvement in squats with the arms up. The 
patient reported no pain at the end of this session.
4.1.4 myoActivation session 4
One month later, the patient again reported that her low back pain no longer 
bothered her. She reported that the left knee pain returned on stopping MgBis/K2/
D3, so she restarted them. Based on the repeat cycles of assessment to determine 
the most restrictive and painful BASE tests [116], the right lumbar paraspinal, right 
hamstring, left gluteus medius and left iliopsoas were sequentially activated. Based 
on core BASE tests, the left knee scars were also re-released.
Four months after initial assessment, she only had minimal left knee pain with 
long walks, was sleeping, and was attending school full time with no absences. She 
required no prescribed or over-the-counter analgesia medications. On examination, 
she had normal movements in all core BASE tests with no pain. She was discharged 
from CPS care and advised to slowly wean MgBis/K2/D3.
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4.1.5 Key points
• During examination, it is important to view as much skin as possible to find 
scars that patients do not remember or acknowledge are present.
• Scar found in the region of most restrictive or painful myoActivation BASE test 
should be released even if they are small, look normotrophic and are reported 
as asymptomatic.
• Scars may have to be re-released on subsequent myoActivation sessions.
• myoActivation is unique in enabling the unravelling of multiple contributors to 
pain, as in this case with low back and left knee pains.
• The patient-physician relationship is enhanced by hands-on examination and 
demonstration of change with sequential examinations.
• In children and adolescents, it is important to utilise techniques to minimise 
procedural needling pain.
• As a component of multidisciplinary care, myoActivation enhances recovery, 
even in patients with a history of years in pain.
4.2 Case 2: non-verbal patient
An 18-year old, 46 kg, non-verbal, wheelchair bound male with cerebral palsy 
(Gross Motor Function Classification System V), global developmental delay and 
seizures, was referred to the CPS. His paediatrician requested that the CPS deter-
mine if a series of myoActivation sessions might help with ongoing management of 
worsening bilateral leg spasms and pain. The patient had multi-physician paediatric 
care of his condition and was optimised on multiple medications (analgesic, anti-
epileptic, and antispasmodic).
His carer believed that his pain was focused to his legs and was worsened with 
touching his legs or changing his diaper. It would take him 30–45 minutes to settle 
and seem calm after diaper changes or turns. Benzodiazepine rescue medication 
was used to help with spasms at these times. There was no specific pain pattern, 
with the pain occurring daily and restricting ability to move him and change 
diapers. There were no changes in skin colour or temperature and no oedema. Each 
night he is moved every 2 hours as he is unable to move himself; however, his carer 
felt that sleep was further disturbed by pain. He could not tolerate lying prone.
Multiple surgeries in the past included: posterior spinal instrumentation 
and fusion T3-Pelvis; right femoral head excision and subtrochanteric valgus 
osteotomy; circumferential release of capsule right hip; right and left pelvic 
osteotomy; left femoral osteotomy; and bilateral leg soft tissue releases and Botox 
injections. His imaging confirmed normal healing and no complications related to 
his multiple surgeries.
A complete myoActivation assessment examination could not be performed 
given his non-verbal and wheelchair-bound status. Lying flat multiple bilateral 
scars were noted from the listed surgeries. His right leg was shortened and exter-
nally rotated. There was a torso shift to the right and the pelvis was lower on the 
right. The right knee was hyper-flexed. The left iliopsoas, rectus femoris and vas-
tus medialis appeared to be in sustained contraction. He was started on MgBis/K2/
D3 supplements. One month after initial assessment, scar release was performed 
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under anaesthesia to release all the right-sided leg scars. Scar release consisted of 
sequential perforation needling of the scar using a 30 g hollow bore needle, using 
sterile technique.
Two months after initial assessment, myoActivation scar release was done to 
release all the left sided leg scars and activate the left iliopsoas, left rectus femoris 
and left vastus medialis under anaesthesia.
At follow up 1 month later, 3 months after initial assessment, his caregiver 
reported that he was much happier with no further episodes of crying out in pain with 
movement or diaper changes. He was also able to lie on his front without any issues.
4.2.1 Key points
• It is difficult to assess pain in a non-verbal patient.
• Children and adolescents with developmental delay may not be able to partici-
pate in a structured myoActivation examination; therefore, the pain physician 
will have to rely on parent or carer observations (most painful movements or 
triggers of pain, most comfortable positions when awake and during sleep).
• In a non-verbal patient, clinical experience and acumen determine if there is a 
myofascial component to the patient’s pain and help direct therapy to the most 
likely sources of myofascial pain.
• As in developmentally normal children, techniques to minimise procedural 
needling pain are essential, as in this case where multiple scars were released 
utilising procedural sedation.
4.3  Case 3: patient requiring general anaesthetic for release of foot scar,  
distant from pain site
A 14-year old, 57 kg male was referred to the CPS for management of chronic 
left shoulder pain of 7 months duration. His pain was severe, graded as 8/10 on a 
visual analogue scale, localised to the left shoulder with no radiation. There was no 
inciting event to his pain. The pain was exacerbated by any movement of his shoul-
der. He had mild left sided hemiplegia secondary to removal of a thalamic astrocy-
toma at age 6. He had undergone a left ankle tendon transfer at age 13. He reported 
that pain significantly affected his ability to fall and stay asleep. His TiLT inventory 
revealed he had had a fractured left ankle, but no MVAs. He had scars related to the 
above surgeries as well as scars from his right sided venous access device, which was 
inserted at the time of diagnosis of his astrocytoma and removed a year later upon 
successful treatment of his oncological presentation. He was otherwise healthy, and 
his family history was unremarkable.
He was assessed by his orthopaedic surgeon, neurologist and oncologist. 
Previous classical examination, imaging (X-rays, CT and MRI) and bloodwork 
revealed no remedial cause of his pain and no recurrence of his astrocytoma. 
Prior to referral to CPS, he was already integrated with regular physiotherapy and 
intermittent massage therapy. Medications at initial assessment were as required 
tramadol, acetaminophen, and ibuprofen. myoActivation examination revealed 
a myofascial component to his pain. In view of distressing pain symptoms, it was 
agreed that myoActivation should be performed at the initial assessment to help 
relieve his pain. Written consent was obtained and myoActivation information 
given to the family. Distraction techniques and vapocoolant spray were used to 
minimise procedural pain.
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The left external oblique, left subscapularis, left platysma were released based 
on structured regional tests for the shoulder [116]. After this first myoActivation 
session, the patient experienced immediate improvement in range of motion of 
the left shoulder and decreased pain. Eight days after this myoActivation session 
the patient reported that his left shoulder pain was “way better than before” and 
his mum reported that he was complaining less about his shoulder and was able to 
sleep better. He had some ongoing left shoulder pain. Repeat myoActivation was 
performed at one-month intervals using BASE tests and regional test for shoulder 
function. On the fourth and final myoActivation session his left foot scars were 
released. As foot scars can be painful, even with appropriately applied topical 
anaesthetic and vapocoolant spray, it was agreed to release these scars with proce-
dural sedation using standard anaesthetic monitoring and care.
At the time of discharge, 3 months after initial assessment, he had no pain, he 
was able to function physically within the restrictions of his existing hemiplegia, 
but with no pain, and was attending school full time. He was discharged from CPS 
care and advised to slowly wean MgBis/K2/D3. Fourteen months after discharge he 
remains pain free.
4.3.1 Key points
• In the presentation of severe ongoing pain, it is sometimes important to 
address regional tests, like the shoulder in this case before addressing potential 
myofascial triggers in BASE tests.
• For some children and adolescents, there is a need for a general anaesthetic 
to perform needling of scars or trigger points: for example, in anxiety/mood 
disorder, young age, non-verbal patients, or where it will be considered too 
painful (e.g., foot scars) as in this case.
• Distant site same-side scars can be clinically important with respect to the 
tension they create through myofascial chains and biotensegrity principles 
described above. For example, left foot scar release to resolve left shoulder pain 
as outlined in this case.
4.4  Case 4: standard myoActivation assessment and treatment of  
multisite pain
A 15-year-old, 57 kg female was referred to the CPS by her orthopaedic physician 
for management of right knee pain of 3 years duration with a diagnosis of “possible 
tendonitis or tendinosis of medial hamstring” with normal blood work and imaging 
(X-rays and MRI). Her main hobby was horse riding and she had sustained multiple 
injuries related to her recreational activities. She related her knee pain to one of 
these injuries, 3 years ago, when she was bucked off her horse and then the horse 
stood on her right knee. Immediately after this injury, she attended the local ER 
and was discharged after normal imaging. She initially mobilised with crutches and 
gradually regained physical functioning over the course of the subsequent 2 months.
She described her current pain as dull and achy with stabbing pain elements 
radiating up her leg and down into her calf. Pain was aggravated by running, horse 
riding, doing squats, or any other physical activities or exercise. She had to wear a 
knee brace and only used the left stirrup when riding her horse as use of the right 
stirrup aggravated her right knee pain. She reported no effect on mood related to her 
pain. She had not been absent from school in the previous 3 months. She reported 
that pain sometimes affected her ability to fall asleep. Her TiLT inventory revealed 
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multiple horse-riding related injuries. She reported that she had scars from a recent 
laparoscopic appendicectomy and scars on her right knee from a wire penetrating 
injury when she was aged 6. She had been using over-the-counter simple analgesia as 
required. She was otherwise healthy and her family history was unremarkable.
myoActivation examination revealed unreported scars on the right knee and 
the abdomen, fascia in tension, and multiple muscles in sustained contraction. A 
myofascial component to her pain was diagnosed. She was enrolled in the 3P care 
plan. She was started on MgBis/K2/D3. Written information about myoActivation 
was given to the family.
4.4.1 myoActivation session 1
Five weeks later she reported feeling better and stronger, but no real change in 
her knee pain. It was deemed appropriate to proceed with myoActivation at this 
time. Written consent was obtained. Distraction techniques, vapocoolant spray and 
topical anaesthetic for scars were used to minimise procedural pain. All needling 
was done using sterile technique.
The right thoracic paraspinal, and right gluteus medius were sequentially acti-
vated based on the repeat cycles of assessment to determine the most restrictive and 
painful BASE tests [116]. The three appendicectomy scars and right knee scar were 
in regions of worst BASE tests so they were considered significant and released. 
After this first myoActivation session, the patient experienced immediate improve-
ment in pain and range of motion in all BASE tests.
4.4.2 myoActivation session 2
Three weeks after her first myoActivation session, the patient reported that 
her right knee pain had moved down to the inner aspect of the right calf. The 
pain felt was less than on initial assessment. She reported that she could sit in 
saddle, horse riding for longer, but found eversion of her ankles painful. The 
left iliopsoas and left rectus abdominis were sequentially activated based on the 
repeat cycles of assessment to determine the most restrictive and painful BASE 
tests [116]. The three appendicectomy scars were again in regions of worst BASE 
tests so they were considered significant and re-released. After this myoActiva-
tion session, the patient experienced immediate improvement in pain and range 
of motion in all BASE tests.
Three months after initial assessment, she reported she could move better, 
had less pain, was horse riding for much longer with both feet in the stirrups. She 
required no over-the-counter analgesia medications. On examination, she had 
normal movements in all core BASE tests with no pain. She was discharged from 
CPS care and advised to slowly wean MgBis/K2/D3.
4.4.3 Key points
• The site of pain may not be the true source of pain. The right hamstrings were 
never activated, even though they were the initial site of pain.
• Release of a scar from the youngest age in the region of most restrictive or 
painful myoActivation BASE test can make clinically substantial change, as 
was the case for this girl.
• Scars acquired after onset of pain may also play an important role in a myo-
fascial pain presentation.
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• This case again illustrates that myoActivation, as a component of multidisci-
plinary care, enhances recovery even in patients with a history of years in pain 
and multiple injuries.
4.5  Case 5: standard myoActivation assessment and treatment of chronic  
multi-site pain secondary to trauma related pelvic and femoral fractures
A 16-year old, 57 kg, female was referred to the CPS for management of multi-
site pain related to injuries sustained when hit by a car whilst crossing a road. She 
was referred by her orthopaedic surgeon, 1 year following injury, when ongoing 
recovery of physical functioning was hampered by multisite pain. She had been fit 
and healthy prior to this accident.
She was a pedestrian who was struck on the right side and knocked down sus-
taining multiple pelvic ring fractures and a left femoral fracture. She sustained 
no other injuries. She required external fixators and an intramedullary femoral 
rod to stabilise her fractures and control blood loss at the time of admission. 
She was an inpatient in hospital for a month and then transferred for inpatient 
rehabilitation at a local rehabilitation centre. The external fixator was removed 
2 months after application. She was discharged from the rehabilitation centre 
5 months after the date of her presenting injury. She continued with ongoing 
outpatient physiotherapy, kinesiology, daily exercises and regular counselling 
but had recently stopped seeing a physiotherapist due to lack of financial sup-
port. Imaging confirmed normal healing and no complications related to the 
surgical sites.
The pain was multisite, affecting the upper, mid and low back, left knee, bilat-
eral thighs, and bilateral ankles with no radiation and no motor or sensory deficits. 
Her pain was variable and intermittent, but aggravated by exercise. She had been 
absent from school for 5 days in the previous 3 months due to pain. She reported 
that pain also affected her ability to fall and stay asleep. Her lifetime trauma his-
tory revealed no other injuries. She took ibuprofen as required. She was otherwise 
healthy and her family history was unremarkable.
myoActivation examination revealed a myofascial component to her pain. Scars 
were noted from the external fixator and at the site of the left intramedullary nail. 
There were also abrasion scars from the injury on the left thigh and hip. She was 
enrolled in the 3P care plan and was started on MgBis/K2/D3. Written myoActiva-
tion information was given to the family.
One month later, there was a reduction in pain with improved fluidity of move-
ments just with the addition of MgBis/K2/D3 and re-engagement with physiother-
apy. It was deemed appropriate to proceed with myoActivation at this one-month 
follow-up visit, based on her very stoical character. Written consent was obtained. 
Distraction techniques and vapocoolant spray were used to minimise procedural 
pain. Fascial densification, muscles in sustained contraction and the scars in areas 
of most significant BASE tests [116] were released. Release of the surgical scars and 
the scars related to the injury made a clinically significant change in pain and range 
of motion during these sessions.
With such significant injuries and multiple areas required to be treated, she 
required nine myoActivation session in the course of the following year whilst 
integrated with the CPS. At the time of discharge, 16 months after initial assess-
ment, she was able to function physically with no restrictions and minimal 
pain. She was sleeping well and successfully graduated from school with good 
marks. She noted that her scars were paler, flatter and less obvious than at the 
start of therapy. She was discharged from CPS care and advised to slowly wean 
MgBis/K2/D3.
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4.5.1 Key points
• Patient reported change in function, just related to institution of the 3P 
approach, massage, and MgBis/K2/D3, helps to confirm a myofascial compo-
nent to pain.
• This approach, with the addition of myoActivation, can have a substantial 
impact even in the presence of such devastating previous injuries.
• Release of the surgical scars and the scars related to the injury made clinically 
significant change for this patient.
The cases cited above have provided a view of how scars have made a substan-
tial impact in pain presentation. Scar release (using a needling technique) helped 
make meaningful change for these patients, often when all other avenues of classic 
medical care for pain aetiology and resolution had been exhausted. Not only is this 
rewarding for the patients and their families, but also the CPS team who are helping 
them in their journey to recovery.
5. Conclusion
Humans exhibit biotensegrity, where each individual part of the organism 
combines with the mechanical system to create an integrated functional movement 
unit. All structures of the human body are intricately connected through skin and 
the myofascial system, they are in a continual process of change dependant on 
and adapting to the forces acting on and within them. When tissue is breached by 
surgery or injury, the healing process leads to the formation of scar tissue. Scars can 
limit normal movement of underlying and remote tissues. Defective fascial sliding, 
secondary to scars, generates anomalous tension that affects the fascial continuum 
and may lead to distorted biomechanics and chronic pain.
Scars are common in the paediatric population and are significant contributory 
factors to chronic pain. Many years, even decades, may pass between scar acquisi-
tion and the development of biomechanical dysfunction or myofascial pain. A 
subsequent trauma may be the inciting event as force transmission throughout the 
body is changed by a scar. Hence, it is important to assess the TiLT inventory, and 
characteristics of all scars, even when they appear to look “normal”.
There are many characteristics of a scar that disrupt the myofascial system, 
which have been highlighted in the cases discussed. When scars are deemed sig-
nificant, scar release should be considered as one component in a multidisciplinary 
approach to address the whole biopsychosocial aspects of chronic pain [136]. Scar 
and myofascial release, with soft tissue mobilisation or needling techniques, can 
result in immediate and sustainable improvements in pain, flexibility, and range of 
motion [116]. When contemplating scar release, consideration should be given to 
minimising procedural pain and to ensure support for any emotional reactions that 
may occur immediately or within the hours following scar release.
Research is required to ascertain the exact characteristics of a scar that deter-
mine whether it will have a significant contribution to myofascial dysfunction and 
chronic pain. The cases presented above illustrate that these investigations must 
recognise the multiple and complex biopsychosocial factors that contribute to a 
myofascial chronic pain presentation.
Whilst definitive answers are awaited, we need to think beyond scars as just 
being innocuous mementos of the past. Clinical experience indicates that they may 
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be restrictive barriers, exerting pervasive biomechanical and nociceptive effects in 
the present. Left untreated, that “strange power” of a scar may go on to have substan-
tial impact in the future as well.
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